Beschreibung

Michael D. WendtProtein-Protein Interactions as Drug TargetsShaomeng Wang , Yujun Zhao , Denzil Bernard , Angelo Aguilar , Sanjeev KumarTargeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapeutics Kurt Deshayes , Jeremy Murray , Domagoj VucicThe Development of Small-Molecule IAP Antagonists for the Treatment of Cancer John F. Kadow , David R. Langley , Nicholas A. Meanwell , Michael A. Walker , Kap-Sun Yeung , Richard PracittoProtein-Protein Interaction Targets to Inhibit HIV-1 Infection Nicholas A. Meanwell , David R. LangleyInhibitors of Protein-Protein Interactions in Paramyxovirus Fusion a Focus on Respiratory Syncytial VirusAndrew B. Mahon , Stephen E. Miller , Stephen T. Joy , Paramjit S. AroraRational Design Strategies for Developing Synthetic Inhibitors of Helical Protein Interfaces Michael D. WendtThe Discovery of Navitoclax, a Bcl-2 Family Inhibitor 

Rezensionen ( 0 )
Every Friday we give gifts for the best reviews.
The winner is announced on the pages of ReadRate in social networks.
Zitate (0)
Sie können als Erste ein Zitat veröffentlichen.
Top